IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Oracle Investment Management Inc

Q2 2019 Holdings

Filed 2019-08-14 | 18 holdings | $2.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$1.5M6,36876.3%
Quidel CorpCOM74838J101$105.9K1,785,2645.4%
Accelerate Diagnostics IncCOM00430H102$99.7K4,356,3635.1%
Amarin Corp PLCSPONS ADR NEW023111206$99.5K5,128,9705.1%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$73.3K1,672,9503.8%
Dermira Inc(DERMEUR)COM24983L104$16.8K1,760,0720.9%
Motus GI Hldgs IncCOM62014P108$11.4K3,766,6660.6%
Soleno Therapeutics IncCOM NEW834203200$10.7K3,813,5580.5%
Opko Health Inc(OPK)COM68375N103$9.0K3,686,1940.5%
Vermillion IncCOM NEW92407M206$8.7K9,825,2890.4%
Biolase IncCOM NEW090911207$7.6K5,173,2500.4%
Pacific Biosciences Calif in(PACB)COM69404D108$6.7K1,110,6660.3%
Cigna Corp New(CI)COM125523100$4.7K29,6530.2%
Agenus Inc(AGENEUR)COM NEW00847G705$4.2K1,408,9180.2%
Contrafect Corp(CFRXEUR)COM212326102$3.2K6,356,6490.2%
Accelerate Diagnostics IncCallCOM00430H102$808180,0000.0%
Biohaven Pharmactl Hldg Co L(BHVN)CallCOMG11196105$692458,8000.0%
Amarin Corp PLCCallSPONS ADR NEW023111206$478650,7000.0%